October 2013 – International Journal of Cardiology study published

Announcement Date: October 9, 2013

October 9, 2013 – Study published in the International Journal of Cardiology questions results of the PLATO trial, finding that “an estimated 23 definite or possible cardiovascular events or deaths on ticagrelor (Brilinta) were either not submitted for adjudication, inactivated, deleted or were downgraded to ‘softer’ endpoints.”